What is LexaMed?
LexaMed operates as a contract laboratory and consulting firm, specializing in providing critical testing services for manufacturers in the medical device and pharmaceutical sectors. The company's comprehensive service portfolio includes lot release testing, microbial stability studies, and various validation services, all designed to ensure stringent adherence to industry standards. With a strong emphasis on quality service and timely delivery, LexaMed holds key certifications such as ISO 13485 and ISO 17025, positioning itself as a vital partner for clients navigating complex regulatory landscapes and aiming to enhance product safety through expert consulting and laboratory analysis.
How much funding has LexaMed raised?
LexaMed has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for LexaMed?
The substantial, large-scale late-stage funding indicates LexaMed is poised for significant expansion and potentially further integration into the supply chain for medical device and pharmaceutical innovation. This capital infusion is likely to fuel advancements in service offerings, capacity expansion, and potentially strategic acquisitions to broaden its market reach and technological capabilities. The company's focus on compliance and quality suggests future investments will prioritize maintaining its high standards while scaling operations to meet growing industry demands.
See full LexaMed company page
